However, it should be emphasized that although the majority of liver metastases in patients with prostate cancer are PSMA positive, some may be PSMA negative and therefore can be missed on [68Ga]Ga-PSMA PET/CT [36]. This evidence concerns the gene FOLH1 and prostate cancer.